136 related articles for article (PubMed ID: 28074607)
1. The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients.
Kruizinga MD; Bresters D; Smiers FJ; Lankester AC; Bredius RGM
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28074607
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
3. Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients.
Clark A; Hemmelgarn T; Danziger-Isakov L; Teusink A
Pediatr Transplant; 2015 May; 19(3):326-31. PubMed ID: 25712369
[TBL] [Abstract][Full Text] [Related]
4. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
[No Abstract] [Full Text] [Related]
5. Efficacy and tolerability of intravenous pentamidine isethionate for Pneumocystis jiroveci prophylaxis in a pediatric oncology population.
Orgel E; Rushing T
Pediatr Infect Dis J; 2014 Mar; 33(3):319-21. PubMed ID: 24030353
[TBL] [Abstract][Full Text] [Related]
6. Safe and Effective Prophylaxis with Bimonthly Intravenous Pentamidine in the Pediatric Hematopoietic Stem Cell Transplant Population.
Levy ER; Musick L; Zinter MS; Lang T; Cowan MJ; Weintrub PS; Dvorak CC
Pediatr Infect Dis J; 2016 Feb; 35(2):135-41. PubMed ID: 26418240
[TBL] [Abstract][Full Text] [Related]
7. Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation.
DeMasi JM; Cox JA; Leonard D; Koh AY; Aquino VM
Pediatr Infect Dis J; 2013 Sep; 32(9):933-6. PubMed ID: 23538522
[TBL] [Abstract][Full Text] [Related]
8. Safety and Effectiveness of Intravenous Pentamidine for Prophylaxis of Pneumocystis jirovecii Pneumonia in Pediatric Hematology/Oncology Patients.
Solodokin LJ; Klejmont LM; Scipione MR; Dubrovskaya Y; Lighter-Fisher J; Papadopoulos J
J Pediatr Hematol Oncol; 2016 Aug; 38(6):e180-5. PubMed ID: 27164533
[TBL] [Abstract][Full Text] [Related]
9. Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.
Kim SY; Dabb AA; Glenn DJ; Snyder KM; Chuk MK; Loeb DM
Pediatr Blood Cancer; 2008 Apr; 50(4):779-83. PubMed ID: 17635000
[TBL] [Abstract][Full Text] [Related]
10. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
12. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia.
Weinthal J; Frost JD; Briones G; Cairo MS
J Clin Oncol; 1994 Jan; 12(1):136-40. PubMed ID: 8270969
[TBL] [Abstract][Full Text] [Related]
13. Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease.
Kimura M; Tanaka S; Ishikawa A; Endo H; Hirohata S; Kondo H
Rheumatol Int; 2008 May; 28(7):673-6. PubMed ID: 18080124
[TBL] [Abstract][Full Text] [Related]
14. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
15. Incidence of
Chiu CY; Ching PR
J Fungi (Basel); 2023 Mar; 9(4):. PubMed ID: 37108861
[TBL] [Abstract][Full Text] [Related]
16. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A38-49. PubMed ID: 11577363
[TBL] [Abstract][Full Text] [Related]
17. The use of intravenous pentamidine as prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection.
Schroeder KE; Barton SE
Int J STD AIDS; 1994; 5(5):353-5. PubMed ID: 7819354
[TBL] [Abstract][Full Text] [Related]
18. Inhaled pentamidine for Pneumocystis jiroveci prophylaxis in a heart transplant recipient with allergy for trimethoprim sulfamethoxazole.
Altintas G; Diken AI; Diken OE; Hanedan O; Kucuker SA
Exp Clin Transplant; 2011 Feb; 9(1):72-3. PubMed ID: 21605028
[TBL] [Abstract][Full Text] [Related]
19. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
Gupta M; Stephenson K; Gauar S; Frenkel L
Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
[No Abstract] [Full Text] [Related]
20. Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.
McCollam S; Lewis JS; Bubalo J; Diaz A
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0083322. PubMed ID: 36214573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
